What is Januvia?

Januvia, also known as Sitagliptin, is a dipeptidyl peptidase-4 (DPP-4) inhibitor manufactured by Merck.  Januvia was introduced to the market in October of 2006 as a once-daily prescription drug used to treat those diagnosed with Type-2 diabetes.  If used in conjunction with proper diet and exercise it helps lower blood sugar levels in patients with type 2 diabetes.  However, shortly after it was introduced to the market, Januvia was linked to pancreatic disease such as cancer.

Additional Januvia FAQs

Featured Januvia Law Firm

Nager, Romaine & Schneiberg Co., L.P.A.

NO REASON TO SETTLE FOR LESS
Our Attorneys Have the Skills, Experience and Knowledge to Provide You with Effective and Strong Representation that You Need and Deserve!
Available 24/7

Captcha Image